Risk of Cardiovascular Events after Acute Exacerbations of Chronic Obstructive Pulmonary Disease in Patients Receiving Long-Term Low-Dose Azithromycin
Am J Respir Crit Care Med. 2024 Mar 19. doi: 10.1164/rccm.202309-1699LE. Online ahead of print.NO ABSTRACTPMID:38502239 | DOI:10.1164/rccm.202309-1699LE
Source: Am J Respir Crit Car... - Category: Intensive Care Authors: Tommaso Bucci Dennis Wat Dilip Nazareth Sarah Sibley Dan Wootton Gregory Yh Lip Freddy Frost Source Type: research
More News: Azithromycin | Cardiology | Cardiovascular | Chronic Obstructive Pulmonary | Heart | Intensive Care | Zithromax